BioCentury
ARTICLE | Financial News

Replidyne raises $62.5 million

September 9, 2005 1:47 AM UTC

Infectious disease company Replidyne (Louisville, Colo.) raised $62.5 million in a series D round led by new investors Duquesne; Healthcare Investment Partners; and MDS Capital. Existing investors Hea...